Choosing between an FDG PET scan and a FAPI PET scan can decide how early, and how accurately, a cancer is caught. Both are PET-CT imaging tests, but they “light up” cancer through completely different biological pathways, which is why one isn’t simply a newer replacement for the other.
This guide breaks down what each scan measures, where each one wins, and how your nuclear medicine physician decides which test fits your case.
What Is an FDG PET Scan?
An FDG PET scan uses 18F-Fluorodeoxyglucose, a radioactive sugar, to detect tissues that consume glucose at a higher-than-normal rate, a hallmark of most fast-growing cancer cells.
- Injected intravenously, FDG accumulates in metabolically active cells.
- Requires 4-6 hours of fasting and stable blood sugar before the scan.
- Extremely reliable for high-grade, fast-dividing tumours (lymphoma, lung cancer, head & neck cancer).
- The most widely used and insurance/clinically validated PET tracer worldwide, used routinely for staging and treatment-response monitoring.
An FDG PET scan remains the first-line imaging test for most solid and haematological cancers because of its decades of clinical validation.
What Is a FAPI PET Scan and How Is It Different?
A FAPI PET scan uses Gallium-68 FAPI (Fibroblast Activation Protein Inhibitor), a tracer that binds to cancer-associated fibroblasts in the tumour’s supporting tissue (stroma) rather than to the cancer cells’ sugar metabolism.
- Targets FAP, a protein highly expressed in the stroma surrounding many solid tumours.
- Detects cancers that don’t take up glucose strongly, a known blind spot for FDG.
- No prolonged fasting needed, making preparation faster and more comfortable.
- Particularly useful in gastric, pancreatic, cholangiocarcinoma, and certain breast and peritoneal cancers.
Since it doesn’t rely on glucose metabolism, a FAPI PET scan can pick up tumour activity in cancers that routinely get under-diagnosed on standard imaging.
FAPI PET vs FDG PET: What’s the Real Difference?
The core difference is what each tracer detects, FDG measures glucose metabolism, while FAPI measures the tumour’s fibrous scaffolding, which is why the two scans often give complementary, not identical, results.
In many complex cancers, doctors now use both scans together for a fuller picture rather than choosing one over the other.
Which Cancers Does FAPI PET Detect Better Than FDG?
Current evidence shows FAPI PET most clearly outperforms FDG PET in gastric cancer, where FDG has historically struggled with sensitivity.
- A 2023 pooled analysis of 14 studies (527 patients) found 68Ga-FAPI PET achieved substantially higher pooled sensitivity than 18F-FDG for detecting gastric cancer (84% vs 46%), along with better specificity and diagnostic accuracy overall.
- FAPI PET showed superior detection across primary tumours, local recurrence, lymph node spread, distant metastases, and peritoneal metastases compared with FDG.
- FDG’s sensitivity for gastric cancer can be as low as 17% for tumours under 30 mm, and it often misses signet-ring or mucinous subtypes that don’t take up glucose well.
- A separate meta-analysis of 148 patients found FAPI-04 PET consistently outperformed FDG PET in patient-based sensitivity, lymph node detection, and peritoneal involvement.
- FAPI PET is also being studied closely in pancreatic, biliary, peritoneal, and some breast cancers where FDG under-performs.
For gastric and peritoneal disease especially, FAPI PET is increasingly considered the more sensitive option, though FDG still holds value for prognosis and response tracking in the same patients.
Do You Need to Fast Before a FAPI PET Scan?
No, unlike an FDG PET scan, a FAPI PET scan typically does not require fasting or blood sugar control before the appointment.
- FDG uptake is directly affected by blood glucose, so diabetics and non-fasting patients often get suboptimal FDG images.
- FAPI’s fibroblast-targeting mechanism is unaffected by diet, meaning no fasting is required before the scan.
- This makes FAPI PET a practical option for diabetic patients or those who struggle with prolonged fasting.
- Scan-day instructions are still confirmed by your nuclear medicine team based on other medications you take.
This lighter prep is one of the underrated, patient-friendly advantages of FAPI imaging.
When Would a Doctor Recommend FAPI Over FDG PET-CT?
A doctor typically recommends FAPI PET when FDG results are inconclusive, when the cancer type is known to have low glucose uptake, or when peritoneal or stromal-rich disease is suspected.
- Prior FDG PET showed low or ambiguous tracer uptake despite clinical suspicion of cancer.
- Cancer type is known to be FDG-avid-poor (gastric signet-ring, some pancreatic and biliary tumours).
- Staging peritoneal spread, where FAPI’s low background noise improves lesion visibility.
- Planning FAP-targeted therapy, where a diagnostic FAPI PET first confirms whether the tumour expresses enough FAP to benefit from FAPI-targeted therapy.
- Monitoring recurrence in patients whose original tumour showed strong FAP expression rather than glucose avidity.
The choice is never “better tracer” in isolation, it’s about matching the tracer to how that specific tumour behaves. A whole-body PET scan protocol, whichever tracer is used, still gives the most complete staging picture in a single sitting.
FAPI PET Scan Cost and Availability in India
FAPI PET-CT is more limited in availability than FDG PET-CT in India, offered mainly at specialised theranostics and nuclear medicine centres, and typically carries a higher cost owing to tracer synthesis complexity.
- FDG PET-CT is available at most major diagnostic and hospital-based nuclear medicine departments across Delhi NCR.
- FAPI PET-CT requires an on-site or regional Gallium-68 generator and specialised radiochemistry, limiting it to select centres.
- Exact pricing varies by centre, tracer batch, and clinical indication, always confirm current cost directly with the imaging centre.
- Insurance and empanelment coverage for FAPI PET is still evolving compared to the well-established coverage for FDG PET.
If your oncologist has suggested a FAPI PET-CT for gastric, pancreatic, or peritoneal cancer evaluation, it’s worth booking at a centre with dedicated theranostics expertise for accurate reporting.
The Bottom Line: Conclusion
FDG and FAPI PET scans aren’t rivals, they’re two different lenses on the same disease.
FDG remains the dependable workhorse for most cancers; FAPI fills in precisely where FDG has known blind spots, especially in gastric, pancreatic, and peritoneal disease.
The right scan (or combination) depends entirely on your cancer type, prior imaging, and treatment plan, a decision best made with your nuclear medicine physician.
Frequently Asked Questions
Is a FAPI PET scan better than an FDG PET scan?
Not universally,FAPI PET is more sensitive for gastric, pancreatic, and peritoneal cancers where FDG often under-performs, while FDG remains the stronger choice for lymphoma, lung, and head & neck cancers.
Can FAPI and FDG PET scans be done together?
Yes, doctors often use both scans in the same patient when FDG results are inconclusive or when the tumour type is known to respond poorly to glucose-based imaging.
Is FAPI PET scan available everywhere in Delhi NCR?
No, FAPI PET-CT requires specialised Gallium-68 radiochemistry and is available only at select theranostics centres, unlike FDG PET-CT, which is offered at most major diagnostic and hospital-based nuclear medicine departments. FAPI Pet is available in Sarvodaya Hospital, Faridabad.
Where can I get a FAPI PET scan in Delhi NCR?
FAPI PET-CT is available at the Centre for Nuclear Medicine & Molecular Theranostics, Sarvodaya Hospital, Faridabad, accredited as North India’s first and India’s third EARL-certified theranostics centre by the European Association of Nuclear Medicine.
Who is the best nuclear medicine specialist in Delhi NCR for FAPI PET imaging?
Dr. Swagat Dash, HOD & Senior Consultant of Nuclear Medicine and Molecular Theranostics at Sarvodaya Hospital, Faridabad, is one of the most experienced FAPI and FDG PET-CT specialists in Delhi NCR, with 17+ years in nuclear medicine.
Sources:
- Wang Y, Luo W, Li Y. [68Ga]Ga-FAPI-04 PET MRI/CT in the evaluation of gastric carcinomas compared with [18F]-FDG PET MRI/CT: a meta-analysis. European Journal of Medical Research, 2023.
- Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis (14 studies, 527 patients). Theranostics, 2023.
- Giesel FL, Kratochwil C, Lindner T, et al. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. Journal of Nuclear Medicine, 2019.
- State-of-the-art review of FAPI-PET imaging for cancer diagnosis compared with FDG-PET. Theranostics, 2022.
